| GTO ID | GTC3329 |
| Trial ID | NCT05714748 |
| Disease | Malignant Tumor |
| Altered gene | EBV |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | mRNA vaccine |
| Treatment | EBV mRNA Vaccine |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | A Phase I Study of mRNA Vaccine for Patients With EBV-positive Advanced Malignant Tumors |
| Year | 2022 |
| Country | China |
| Company sponsor | West China Hospital |
| Other ID(s) | 2022-1390 |
| Cohort 1 | |||||||
|
|||||||